enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Myasthenia gravis is one of the rarest and most concerning ...

    www.aol.com/myasthenia-gravis-one-rarest-most...

    Myasthenia gravis, or MG, is a chronic autoimmune neuromuscular disorder that causes muscle weakness and fatigue. ... swallowing and breathing." ... "With appropriate treatment, many people with ...

  3. Myasthenia gravis - Wikipedia

    en.wikipedia.org/wiki/Myasthenia_gravis

    Myasthenia gravis (MG) is a long-term ... and swallowing. [1] [5] It can result in double vision, ... Both of these treatments have relatively short-lived benefits ...

  4. Efgartigimod alfa - Wikipedia

    en.wikipedia.org/wiki/Efgartigimod_alfa

    The study showed that more participants with myasthenia gravis with antibodies responded to treatment during the first cycle of efgartigimod alfa (68%) compared to those who received placebo (30%) on a measure that assesses the impact of myasthenia gravis on daily function. [4]

  5. Neuromuscular junction disease - Wikipedia

    en.wikipedia.org/wiki/Neuromuscular_junction_disease

    Acquired myasthenia gravis is the most common neuromuscular junction disease.(reference 7) Important observations were made by Patrick and Lindstrom in 1973 when they found that antibodies attacking the acetylcholine receptors were present in around 85% of cases of myasthenia gravis.(reference renamed form 13)(reference 36) The remaining ...

  6. Cartesian Therapeutics Announces Positive Updated Results ...

    lite.aol.com/tech/story/0022/20241203/9312598.htm

    About Myasthenia Gravis . Myasthenia gravis (MG) is a chronic autoimmune disorder that causes disabling muscle weakness and fatigue. For most people with MG, the disease is characterized by the presence of antibodies against the acetylcholine receptor, a protein found on the surface of nerve cells that plays a key role in muscle contraction.

  7. Rozanolixizumab - Wikipedia

    en.wikipedia.org/wiki/Rozanolixizumab

    Rozanolixizumab, sold under the brand name Rystiggo, is a monoclonal antibody used for the treatment of myasthenia gravis. [1] Rozanolixizumab is a humanized and chimeric monoclonal antibody; [4] and is a neonatal Fc receptor blocker. [1] [4]

  8. Pyridostigmine - Wikipedia

    en.wikipedia.org/wiki/Pyridostigmine

    Pyridostigmine is a medication used to treat myasthenia gravis [1] and underactive bladder. [2] It is also used together with atropine to end the effects of neuromuscular blocking medication of the non-depolarizing type. [3] It is also used off-label to treat some forms of Postural orthostatic tachycardia syndrome.

  9. Megaesophagus - Wikipedia

    en.wikipedia.org/wiki/Megaesophagus

    Megaesophagus can also be a symptom of the disease myasthenia gravis. Myasthenia gravis is a neuromuscular disease where the primary symptom is weakness in various body parts of the dog. However, when myasthenia gravis occurs in older dogs it is thought of as an immune-mediated disease. Often when myasthenia gravis is diagnosed in older dogs ...